Literature DB >> 17712533

Mechanisms of tumor growth and metastasis in head and neck squamous cell carcinoma.

Jarrett E Walsh1, Deanne M R Lathers, Angela C Chi, M Boyd Gillespie, Terry A Day, M Rita I Young.   

Abstract

The formation and progression of head and neck squamous cell carcinoma (HNSCC) is multisystemic and involves the immune system, vascularization, and dissemination. Immune involvement includes the subversion of anti-tumor defenses. Vascularization involves both angiogenesis and vasculogenesis. Dissemination involves local tumor invasion as well as distant metastasis through processes including angiogenesis and lymphangiogenesis. Current studies in the dysregulation of various processes, including genetic stability, angiogenesis, lymphangiogenesis, immune regulation, and immune function, are opening opportunities for the development of targeted tumor therapies. The interrelationship of these processes in HNSCC development will be explored in this review.

Entities:  

Mesh：

Year:  2007        PMID： 17712533     DOI： 10.1007/s11864-007-0032-2

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN： 1534-6277


  75 in total

Review 1.  Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization.

Authors:  J M Isner; T Asahara
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

Review 2.  Significance of extracapsular lymph node metastases in patients with head and neck squamous cell carcinoma.

Authors:  Sajeev K Puri; Chun-Yang Fan; Ehab Hanna
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2003-04       Impact factor: 2.064

Review 3.  New insights into the molecular control of the lymphatic vascular system and its role in disease.

Authors:  Leah N Cueni; Michael Detmar
Journal:  J Invest Dermatol       Date:  2006-10       Impact factor: 8.551

4.  Administration of a prostaglandin synthetase inhibitor associated with an increased immune cell infiltrate in squamous cell carcinoma of the head and neck.

Authors:  D S Cross; J L Platt; S K Juhn; F H Bach; G L Adams
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1992-05

5.  In vivo monitoring of the death rate of artificial murine pulmonary micrometastases.

Authors:  L A Liotta; D Vembu; R K Saini; C Boone
Journal:  Cancer Res       Date:  1978-05       Impact factor: 12.701

6.  Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts.

Authors:  E K Rofstad; E F Halsør
Journal:  Cancer Res       Date:  2000-09-01       Impact factor: 12.701

7.  Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer.

Authors:  Rajnish A Gupta; Lovella V Tejada; Beverly J Tong; Sanjoy K Das; Jason D Morrow; Sudhansu K Dey; Raymond N DuBois
Journal:  Cancer Res       Date:  2003-03-01       Impact factor: 12.701

8.  Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia.

Authors:  Laura A Kresty; Susan R Mallery; Thomas J Knobloch; Huijuan Song; Mary Lloyd; Bruce C Casto; Christopher M Weghorst
Journal:  Cancer Res       Date:  2002-09-15       Impact factor: 12.701

9.  3p21, 5q21, 9p21 and 17p13 allelic deletions accumulate in the dysplastic spectrum of laryngeal carcinogenesis and precede malignant transformation.

Authors:  J Sanz-Ortega; C Valor; M C Saez; L Ortega; E Sierra; J Poch; S Hernández; J Sanz-Esponera
Journal:  Histol Histopathol       Date:  2003-10       Impact factor: 2.303

10.  Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization.

Authors:  T Takahashi; C Kalka; H Masuda; D Chen; M Silver; M Kearney; M Magner; J M Isner; T Asahara
Journal:  Nat Med       Date:  1999-04       Impact factor: 53.440
View more
  16 in total

Review 1.  Molecular mechanisms of head and neck cancer.

Authors:  Amit M Deshpande; David T Wong
Journal:  Expert Rev Anticancer Ther       Date:  2008-05       Impact factor: 4.512

2.  Tumor secretion of VEGF induces endothelial cells to suppress T cell functions through the production of PGE2.

Authors:  Jennifer K Mulligan; Steven A Rosenzweig; M Rita I Young
Journal:  J Immunother       Date:  2010 Feb-Mar       Impact factor: 4.456

3.  Immunohistochemical analysis of integrins αvβ3, αvβ5 and α5β1, and their ligands, fibrinogen, fibronectin, osteopontin and vitronectin, in frozen sections of human oral head and neck squamous cell carcinomas.

Authors:  Eva-Maria Fabricius; Gustav-Paul Wildner; Ute Kruse-Boitschenko; Bodo Hoffmeister; Simon L Goodman; Jan-Dirk Raguse
Journal:  Exp Ther Med       Date:  2010-12-02       Impact factor: 2.447

4.  USC-HN2, a new model cell line for recurrent oral cavity squamous cell carcinoma with immunosuppressive characteristics.

Authors:  Sarah M Russell; Melissa G Lechner; Lucy Gong; Carolina Megiel; Daniel J Liebertz; Rizwan Masood; Adrian J Correa; Jing Han; Raj K Puri; Uttam K Sinha; Alan L Epstein
Journal:  Oral Oncol       Date:  2011-06-29       Impact factor: 5.337

Review 5.  Reviewing and reconsidering invasion assays in head and neck cancer.

Authors:  Ronald C Inglehart; Christina S Scanlon; Nisha J D'Silva
Journal:  Oral Oncol       Date:  2014-10-14       Impact factor: 5.337

Review 6.  Immunological treatment options for locoregionally advanced head and neck squamous cell carcinoma.

Authors:  Christopher Schutt; Klaus Bumm; Leonardo Mirandola; Giovanni Bernardini; Nicholas D' Cunha; Lukman Tijani; Diane Nguyen; Joehassin Cordero; Marjorie R Jenkins; Everardo Cobos; W Martin Kast; Maurizio Chiriva-Internati
Journal:  Int Rev Immunol       Date:  2012-02       Impact factor: 5.311

7.  Vasculogenesis driven by bone marrow-derived cells is essential for growth of Ewing's sarcomas.

Authors:  Ling Yu; Bing Su; Mario Hollomon; Yong Deng; Valeria Facchinetti; Eugenie S Kleinerman
Journal:  Cancer Res       Date:  2010-02-02       Impact factor: 12.701

8.  Vasculogenic mimicry contributes to lymph node metastasis of laryngeal squamous cell carcinoma.

Authors:  Wei Wang; Peng Lin; Chunrong Han; Wenjuan Cai; Xiulan Zhao; Baocun Sun
Journal:  J Exp Clin Cancer Res       Date:  2010-06-02

9.  Prognostic impact of expression of Bcl-2 and Bax genes in circulating immune cells derived from patients with head and neck carcinoma.

Authors:  Tomoyuki Tano; Masato Okamoto; Shin Kan; Koh-Ichi Nakashiro; Shigetaka Shimodaira; Shigeo Koido; Sadamu Homma; Mitsunobu Sato; Tomonobu Fujita; Yutaka Kawakami; Hiroyuki Hamakawa
Journal:  Neoplasia       Date:  2013-03       Impact factor: 5.715

10.  Secretion of vascular endothelial growth factor by oral squamous cell carcinoma cells skews endothelial cells to suppress T-cell functions.

Authors:  Jennifer K Mulligan; Terry A Day; M Boyd Gillespie; Steven A Rosenzweig; M Rita I Young
Journal:  Hum Immunol       Date:  2009-02-12       Impact factor: 2.850
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.